These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1453016)

  • 1. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia.
    Wandl UB; Niederle N; Kranzhoff M; Seeber S
    Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response.
    Geissler D; Gastl G; Aulitzky W; Tilg H; Gaggl S; Konwalinka G; Huber C
    Leuk Res; 1990; 14(7):629-36. PubMed ID: 2388474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.
    Estrov Z; Talpaz M; Chou TC; Kurzrock R; Blake M; Gutterman JU
    Leukemia; 1991 Feb; 5(2):101-7. PubMed ID: 2020193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
    Robak T; Korycka A
    Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM).
    Carlo-Stella C; Cazzola M; Ganser A; Bergamaschi G; Pedrazzoli P; Hoelzer D; Ascari E
    Blood; 1988 Oct; 72(4):1293-9. PubMed ID: 3139105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
    Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY
    Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of recombinant human alpha-2b and gamma interferons on bone marrow megakaryocyte progenitors (CFU-Meg) from patients with chronic myelocytic leukemia].
    Tanabe Y; Dan K; Kuriya S; Nomura T
    Rinsho Ketsueki; 1989 Oct; 30(10):1800-5. PubMed ID: 2512397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
    Taniguchi S; Dai CH; Krantz SB
    Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
    J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
    Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
    Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
    Gronthos S; To LB; Haylock DN; Juttner CA
    Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):259-64. PubMed ID: 9017167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
    Marley SB; Davidson RJ; Goldman JM; Gordon MY
    Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.